Lexaria Bioscience Corp. is a biotechnology company focused on the development and commercialization of innovative drug delivery technologies. Headquartered in Vancouver, Canada, the company trades on the OTC Markets under the symbol LXRP. Lexaria’s proprietary DehydraTECH platform is designed to enhance the oral absorption of a broad range of active pharmaceutical ingredients, nutraceuticals and consumer products by improving their bioavailability and onset of action.
Central to Lexaria’s business activities is the application of its DehydraTECH technology to cannabinoid compounds such as CBD and THC, as well as nicotine and various vitamin formulations. By integrating active molecules with specific lipid-based excipients, the platform is intended to facilitate faster uptake in the bloodstream and higher overall exposure compared to unformulated ingredients. Lexaria pursues both in-house product development and licensing arrangements with established consumer goods and pharmaceutical partners.
Over the years, Lexaria has secured multiple patents for its delivery systems and has engaged in preclinical and human clinical studies to validate safety and efficacy. The company’s research spans pain management, inflammation, cardiovascular health and metabolic syndrome, reflecting its pursuit of applications beyond the botanical and nutraceutical markets. Lexaria also collaborates with academic institutions and contract research organizations to advance its pipeline and explore potential new indications.
Founded in 2011, Lexaria Bioscience is led by President and Chief Executive Officer Chris Bunka, who brings extensive experience in the biotech and cannabis sectors. Under his direction, the company continues to scale its intellectual property portfolio and expand licensing opportunities in North America, Europe and Asia. Lexaria’s strategic goal is to establish DehydraTECH as a preferred delivery solution for both established and emerging companies in the pharmaceutical, nutraceutical and consumer packaged goods industries.
AI Generated. May Contain Errors.
Free LXRP Stock Alerts